Clinical Trials

20 enrolled

Burkitt Lymphoma

NCT07205315 2025-12-26

A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic Anemia

Classical hematologyLymphoidOther hematologic neoplasm

28 enrolled

Anemia, Hemolytic, Autoimmune, Burkitt Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell

NCT07162012 2025-12-02

Anti-EBV TCR-T

24 enrolled

Lymphoma, T-Cell, Peripheral, Lymphoma, Extranodal NK-T-Cell

NCT06120166 2025-09-19

Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r DLBCL Clinical Research

18 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT07101705 2025-09-09

An Open-label, Single-arm Clinical Study to Evaluate the Safety and Preliminary Efficacy of OriV508 Injection in Treating Relapsed/Refractory Hematological Malignancies

40 enrolled

LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma

NCT06446128 2025-08-21

A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed or Refractory B Cell Non-Hodgkin Lymphoma(NHL)

20 enrolled

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell

NCT06976437 2025-07-10

A Clinical Study of Allogeneic CD19/BCMA CAR-T Cells for the Treatment of R/R B-cell Malignant Tumors

21 enrolled

LymphoidPlasma cell

Multiple Myeloma, Lymphoma, B-Cell

NCT04139304 2025-06-29

A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma

15 enrolled

Plasmablastic Lymphoma

NCT06092047 2025-05-16

UTAA09 Injection in the Treatment of Relapsed/Refractory Hematolymphatic Malignancies.

10 enrolled

CD19-positive Relapsed or Refractory B-cell Malignancies

NCT06793241 2025-01-27

Donor Derived CD19 CAR-T Cells in the Treatment of R/R B-cell Acute Lymphoblastic Leukemia

15 enrolled

Burkitt Lymphoma

NCT06307600 2025-01-23

The Safety and Efficacy of RD06-03 CART Cell Injection in Patients With R/R Acute B-lymphoblastic Leukemia

9 enrolled

Lymphoma

NCT05651178 2025-01-07

Human CD19-CD22 Targeted T Cells Injection for Refractory/Relapsed Central Nervous System Leukemia/Lymphoma Patients

10 enrolled

Lymphoma, Recurrence

NCT06756321 2025-01-03

A Study of CAR T-Cells in Relapsed/Refractory Hematologic Malignancy

9 enrolled

Leukemia, Lymphoma

NCT06716164 2024-12-04

Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r B-NHL Clinical Research

36 enrolled

Lymphoma, B-Cell

NCT06696833 2024-11-20

Allogeneic CD19-targeted CAR-γδT Cell Infusion Therapy in Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia

18 enrolled

Burkitt Lymphoma

NCT06693973 2024-11-19

An Early Clinical Study Evaluating the Safety and Efficacy of AcNK-Sup003 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

13 enrolled

Lymphoma, B-Cell

NCT06643221 2024-10-16

Allo-X

100 enrolled

Leukemia, Lymphoma, Motor Activity

NCT06633341 2024-10-09

Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-lymphoma

30 enrolled

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT06633354 2024-10-09

Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-ALL

30 enrolled

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT06532643 2024-09-19

Safety and Efficacy of Anti-CD20/CD30 CAR-T Cells in Subjects with Relapsed/Refractory Lymphoma

9 enrolled

Lymphoma

NCT04541108 2024-04-18

Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies

DermatologicHead & NeckLymphoidSarcoma

15 enrolled

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Lymphoma, Melanoma, Sarcoma

NCT05838599 2024-03-12

Combining Topical Imiquimod With Local Radiotherapy for Treatment of Mycosis Fungoides

25 enrolled

Mycosis Fungoides

NCT06224049 2024-03-12

GI-hNeoT-01

6 enrolled

Lymphoma, T-Cell, Epstein-Barr Virus Infections

NCT04662294 2021-11-04

CD 70 CAR T for Patients With CD70 Positive Malignant Hematologic Diseases

LymphoidOther hematologic neoplasmPlasma cell

108 enrolled

Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, Myeloid, Acute

NCT04227015 2020-12-28

A Study of CTA101 UCAR-T Cell Injection in Patients With Relapsed or Refractory CD19+ B-line Hematological Malignancy

72 enrolled

Lymphoma, Non-Hodgkin, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04603872 2020-10-28

CAR-T Cells Combined With Dasatinib for Patients With Relapsed and/or Refractory B-cell Hematological Malignancies

LymphoidOther hematologic neoplasmPlasma cell

120 enrolled

Lymphoma, Non-Hodgkin, Multiple Myeloma, Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04532203 2020-10-26

A Study of CAR-T Cells Therapy for Patients With Relapsed and/or Refractory Central Nervous System Hematological Malignancies

72 enrolled

Lymphoma, Non-Hodgkin, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04532281 2020-10-26

A Study of Murine CD19 CAR-T Therapy for Patients With Relapsed or Refractory CD19+ B-cell Hematological Malignancies

120 enrolled

Lymphoma, Non-Hodgkin, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04532268 2020-08-31

A Study of Humanized CD19 CAR-T Cells Therapy for Patients With Relapsed and/or Refractory B-cell ALL and B-cell NHL

72 enrolled